29-April-2026
Corporate News
 
Dr Reddy's gets Health Canada nod for generic semaglutide injection
29-Apr-2026

Dr Reddy's Laboratories on Wednesday said it has received a notice of compliance (NOC) from Health Canada for its generic semaglutide injection indicated for the management of type-2 diabetes. Dr Reddy's becomes the first company to receive the market authorisation for generic Semaglutide Injection in Canada, ahead of Health Canada's review target date, the company said in a regulatory filing.

News Source:- https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/dr-reddys-gets-health-canada-nod-for-generic-semaglutide-injection/articleshow/130596904.cms
 
 
 

Notes:
1. Copyright and ownership of all content from IMC and other IMC sites belongs to IMC except third-party resources
2. Copyright, intellectual property right, ownership or responsibility of error of other content belong to respective sources
3. Please do not reply to this mail

For suggestions and feedback click here.

Disclaimer:
IMC is not responsible for any kind of loss arising due to the information. You are receiving this newsletter because you have subscribed to this service. To unsubscribe click here.
Head Office : IMC Bldg., IMC Marg, Churchgate, Mumbai - 400 020 India  |   Tel : 91-22-22046633  |   Fax : 91-22-22048508 / 22838281
E-Mail : imc@imcnet.org  |   Website : www.imcnet.org